Filter

Refine by date

—

Refine by collections

  • Thyroid cancer - basic and translational (1)
  • Print
  • Save

Search Results

You are looking at 1 - 1 of 1 items for :

  • "liver metastases" x
  • Thyroid cancer - basic and translational x
Clear All
Ségolène Hescot Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Ségolène Hescot in
Google Scholar
PubMed Close
,
Julien Masliah-Planchon Department of Genetics, Institut Curie, Paris, France

Search for other papers by Julien Masliah-Planchon in
Google Scholar
PubMed Close
,
Pauline du Rusquec Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Pauline du Rusquec in
Google Scholar
PubMed Close
,
Célia Dupain Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Célia Dupain in
Google Scholar
PubMed Close
,
Maud Kamal Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Search for other papers by Maud Kamal in
Google Scholar
PubMed Close
,
Vincent Servois Department of Radiology, Institut Curie, Paris, France

Search for other papers by Vincent Servois in
Google Scholar
PubMed Close
, and
Ivan Bieche Department of Genetics, Institut Curie, Paris, France

Search for other papers by Ivan Bieche in
Google Scholar
PubMed Close

MTC who harbored two somatic variants of unknown significance (VUS) in the RET gene and responded to pralsetinib. A 48-year-old male with no previous medical history was referred to our center for liver metastases discovered during cholecystectomy

Article Type:
Case Report
Collections:
Thyroid cancer - basic and translational
DOI:
https://doi.org/10.1530/ETJ-22-0044
Volume/Issue:
Volume 11: Issue 5
Open access